image
Healthcare - Biotechnology - NASDAQ - US
$ 1.34
-2.9 %
$ 1.93 M
Market Cap
-0.15
P/E
BALANCE SHEET
6.59 M ASSETS
-55.04%
1.3 M LIABILITIES
-69.55%
5.29 M EQUITY
-49.09%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Salarius Pharmaceuticals, Inc.
image
Current Assets 6.52 M
Cash & Short-Term Investments 5.9 M
Receivables 0
Other Current Assets 620 K
Non-Current Assets 66.8 K
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 66.8 K
Current Liabilities 1.3 M
Accounts Payable 603 K
Short-Term Debt 290 K
Other Current Liabilities 407 K
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
ASSETS
Cash & Cash Equivalents 5.9 12.1 29.2 11.1 3.7 9.8 19.2 22.4 66.7 33.9
Short Term Investments 0 0 0 0 0 0 14.1 38.7 27.0 0
Receivables 0 1.6 0 3.9 0 9.94 K 10.4 K 12.2 K 0 0
Inventory 0 (1.6) 0 0 0 0.2 0.4 0.5 0 0
Other Current Assets 0.6 0.8 0.9 0.8 1.9 0.3 0.8 0 0.9 0.4
Total Current Assets 6.5 14.5 30.2 15.8 4.7 10.3 34.5 62.5 94.6 34.2
PP&E 0 0 7.88 K 22.6 K 25 K 74 K 0.3 0.6 0.4 85 K
Intangible Assets 0 0 8.9 8.9 8.9 0 66.4 K 53.9 K 0 0
Goodwill 0 0 8.9 8.9 8.9 0 0 0 0 0
Long Term Investments 0 0 1.6 0 0 0 0 0 2.3 0
Other Long Term Assets 66.8 K 0.1 1.8 0.2 0.3 0 60.6 K 0.1 (2.2) 1.3
Other Assets 0 0 0 0 0 0 0 0 0 0
Total Assets 6.6 14.7 40.8 24.9 13.9 10.4 35.0 63.2 95.1 35.6
LIABILITIES
Accounts Payable 0.6 2.9 1.5 1.9 1.8 0.3 2.0 1.2 0.9 0.6
Short Term Debt 0.3 0 0 0.5 0.5 0 0 0 0 0
Other Current Liabilities 0.4 1.4 0.6 0.4 0.5 4.7 3.8 2.6 1.9 0.5
Total Current Liabilities 1.3 4.3 2.1 2.8 3.3 1.1 5.9 3.9 2.8 1.0
Long Term Debt 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 50.1 K
Other Liabilities 0 0 0 0 0 0 39.2 K 0 40.4 K 41.1
Total Liabilities 1.3 4.3 2.1 2.8 3.3 1.1 5.9 3.9 2.9 42.1
EQUITY
Common Stock 393 225 4.52 K 2.38 K 451 1.81 K 1.78 K 1.68 K 1.57 K 221
Retained Earnings (76.3) (63.8) (32.2) (19.4) (12.1) (133.0) (111.1) (76.6) (37.2) (8.0)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 (2.9) 1.25 K 1.61 K 24.7 K (15.6)
Total Equity 5.3 10.4 38.7 22.2 10.6 9.3 29.1 59.3 92.2 (6.5)
Total Liabilities and Equity 6.6 14.7 40.8 24.9 13.9 10.4 35.0 63.2 95.1 35.6
SHARES OUTSTANDING
Common Shares Outstanding 3.3 2.1 1.7 0.6 0.1 28.8 K 27.6 K 26 K 22.5 K